Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy. Alenazy FO, Harbi MH, Kavanagh DP, Price J, et al. J Thromb Haemost 2023;21:3236-3251.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alenazy FO, Harbi MH, Kavanagh DP, Price J, et al. Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy. J Thromb Haemost 2023;21:3236-3251.
PMID: 37541591